Audit of eligibility of hepatitis C/HIV co-infected patients in the Lothian Regional Infectious Diseases Unit cohort for new HCV protease inhibitor containing regimen

Karen A. Devine*, David Whiteley, Clifford Leen

*Corresponding author for this work

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished - 20 Apr 2012


  • hepatitis C (HCV)
  • HIV
  • protease inhibitors

Cite this